Validity of the 5-fluorouracil plasma concentration in patients having a chemotherapy regime with 5 -fluorouracil

• Conditions: C26.0; Intestinal tract, part unspecified

• Registration Number: DRKS00011486
• Lead Sponsor: Galen DiaConsult GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12-21
• Study Completion: 2018-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 448

Inclusion Criteria

1. Age > 18 years
2. Signed informed consent
3. Having chemotherapy with 5-F

Exclusion Criteria

1. Age < 18 years
2. No informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aim is to estmate the 5-fluorouracil exposition in comparison to the 5-fluorouracil dosage

Secondary Outcome Measures

Name	Time	Method
Relationship between 5-fluorouracil exposition and toxicity